As of 2025-09-15, the EV/EBITDA ratio of Profound Medical Corp (PRN.TO) is -3.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRN.TO's latest enterprise value is 124.71 mil CAD. PRN.TO's TTM EBITDA according to its financial statements is -41.34 mil CAD. Dividing these 2 quantities gives us the above PRN.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 19.2x | 14.4x |
| Forward P/E multiples | 18.7x - 21.5x | 20.1x |
| Fair Price | (34.26) - (35.21) | (31.51) |
| Upside | -717.3% - -734.5% | -667.7% |
| Date | EV/EBITDA |
| 2025-09-12 | -2.18 |
| 2025-09-11 | -2.15 |
| 2025-09-10 | -2.07 |
| 2025-09-09 | -2.24 |
| 2025-09-08 | -2.22 |
| 2025-09-05 | -2.28 |
| 2025-09-04 | -2.43 |
| 2025-09-03 | -2.45 |
| 2025-09-02 | -2.51 |
| 2025-08-29 | -2.50 |
| 2025-08-28 | -2.52 |
| 2025-08-27 | -2.53 |
| 2025-08-26 | -2.53 |
| 2025-08-25 | -2.69 |
| 2025-08-22 | -2.72 |
| 2025-08-21 | -2.70 |
| 2025-08-20 | -2.62 |
| 2025-08-19 | -2.61 |
| 2025-08-18 | -2.73 |
| 2025-08-15 | -2.39 |
| 2025-08-14 | -3.22 |
| 2025-08-13 | -3.24 |
| 2025-08-12 | -3.32 |
| 2025-08-11 | -3.31 |
| 2025-08-08 | -3.32 |
| 2025-08-07 | -3.33 |
| 2025-08-06 | -3.31 |
| 2025-08-05 | -3.27 |
| 2025-08-01 | -3.35 |
| 2025-07-31 | -3.35 |
| 2025-07-30 | -3.28 |
| 2025-07-29 | -3.23 |
| 2025-07-28 | -3.36 |
| 2025-07-25 | -3.31 |
| 2025-07-24 | -3.49 |
| 2025-07-23 | -3.45 |
| 2025-07-22 | -3.46 |
| 2025-07-21 | -3.24 |
| 2025-07-18 | -3.29 |
| 2025-07-17 | -3.34 |
| 2025-07-16 | -3.41 |
| 2025-07-15 | -3.38 |
| 2025-07-14 | -3.40 |
| 2025-07-11 | -3.46 |
| 2025-07-10 | -3.57 |
| 2025-07-09 | -3.55 |
| 2025-07-08 | -3.55 |
| 2025-07-07 | -3.53 |
| 2025-07-04 | -3.52 |
| 2025-07-03 | -3.54 |